Left-sided Pseudomonas aeruginosa endocarditis in patients without injection drug use

Medicine (Baltimore). 2011 Jul;90(4):250-255. doi: 10.1097/MD.0b013e3182252133.

Abstract

We aimed to determine the clinical features, predisposing factors, and outcome of left-sided Pseudomonas aeruginosa endocarditis in persons with no history of injection drug use. We performed a retrospective review of patient medical records from Mayo Clinic (Rochester, MN; Scottsdale, AZ; and Jacksonville, FL) for all cases of left-sided P. aeruginosa endocarditis. We identified 4 cases. We present these cases, as well as a review of the English-language medical literature. Data gathered included the year the case was reported; the valve involved; treatment, including valve replacement surgery; and outcome, if known. Left-sided P. aeruginosa endocarditis in persons without injection drug use is a rare but serious infection, with a history of instrumentation as a common predisposing condition. Valvular surgery is indicated, when possible, for the best chance of survival, along with extended therapy with combination antibiotics for complete recovery.

Publication types

  • Review

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Cardiac Surgical Procedures / methods
  • Databases, Factual
  • Disease Progression
  • Echocardiography, Transesophageal / methods
  • Endocarditis, Bacterial / diagnostic imaging*
  • Endocarditis, Bacterial / mortality*
  • Endocarditis, Bacterial / pathology
  • Endocarditis, Bacterial / therapy
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Pseudomonas Infections / diagnostic imaging*
  • Pseudomonas Infections / mortality*
  • Pseudomonas Infections / pathology
  • Pseudomonas Infections / therapy
  • Pseudomonas aeruginosa / isolation & purification*
  • Recurrence
  • Retrospective Studies
  • Risk Assessment
  • Sampling Studies
  • Severity of Illness Index
  • Substance Abuse, Intravenous
  • Survival Rate

Substances

  • Anti-Bacterial Agents